guanfacine and Psychoses, Drug studies

guanfacine and Psychoses, Drug

guanfacine has been researched along with Psychoses, Drug in 2 studies

Guanfacine: A centrally acting antihypertensive agent with specificity towards ADRENERGIC ALPHA-2 RECEPTORS.

Research Excerpts

Excerpt	Relevance	Reference
" While medications for ADHD are generally well-tolerated, there are common, although less severe, as well as rare but severe adverse events AEs during treatment with ADHD drugs."	2.49	Practitioner review: current best practice in the management of adverse events during treatment with ADHD medications in children and adolescents. ( Banaschewski, T; Buitelaar, J; Coghill, D; Cortese, S; Danckaerts, M; Dittmann, RW; Graham, J; Holtmann, M; Sergeant, J; Taylor, E, 2013)

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (100.00)	24.3611
2020's	0 (0.00)	2.80

Timeframe

Studies, this research(%)

All Research%

pre-1990

0 (0.00)

18.7374

1990's

0 (0.00)

18.2507

2000's

0 (0.00)

29.6817

2010's

2 (100.00)

24.3611

2020's

0 (0.00)

2.80

Authors

Authors	Studies
Kim, RK	1
Chayer, R	1
Cortese, S	1
Holtmann, M	1
Banaschewski, T	1
Buitelaar, J	1
Coghill, D	1
Danckaerts, M	1
Dittmann, RW	1
Graham, J	1
Taylor, E	1
Sergeant, J	1

Studies

Kim, RK

Chayer, R

Cortese, S

Holtmann, M

Banaschewski, T

Buitelaar, J

Coghill, D

Danckaerts, M

Dittmann, RW

Graham, J

Taylor, E

Sergeant, J

Clinical Trials (1)

Trial Overview

Trial	Phase	Enrollment	Study Type	Start Date	Status
Therapeutic Use of Repetitive Transcranial Magnetic Stimulation (rTMS) in Pediatric Autism Spectrum Disorder (ASD) and Attention Deficit Hyperactivity Cohorts (ADHD): a Randomized, Sham-controlled Study.[NCT06069323]		80 participants (Anticipated)	Interventional	2023-06-01	Recruiting
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Trial

Phase

Enrollment

Study Type

Start Date

Status

Therapeutic Use of Repetitive Transcranial Magnetic Stimulation (rTMS) in Pediatric Autism Spectrum Disorder (ASD) and Attention Deficit Hyperactivity Cohorts (ADHD): a Randomized, Sham-controlled Study.[NCT06069323]

80 participants (Anticipated)

Interventional

2023-06-01

Recruiting

[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Reviews

1 review available for guanfacine and Psychoses, Drug

Article	Year
Practitioner review: current best practice in the management of adverse events during treatment with ADHD medications in children and adolescents. Journal of child psychology and psychiatry, and allied disciplines, 2013, Volume: 54, Issue:3 Topics: Adolescent; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Blood Pressure	2013

Article

Year

Practitioner review: current best practice in the management of adverse events during treatment with ADHD medications in children and adolescents.

Journal of child psychology and psychiatry, and allied disciplines, 2013, Volume: 54, Issue:3

Topics: Adolescent; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Blood Pressure

2013

Other Studies

1 other study available for guanfacine and Psychoses, Drug

Article	Year
Psychosis associated with guanfacine. Journal of clinical psychopharmacology, 2015, Volume: 35, Issue:2 Topics: Adrenergic alpha-Agonists; Attention Deficit Disorder with Hyperactivity; Child, Preschool; Delirium	2015

Article

Year

Psychosis associated with guanfacine.

Journal of clinical psychopharmacology, 2015, Volume: 35, Issue:2

Topics: Adrenergic alpha-Agonists; Attention Deficit Disorder with Hyperactivity; Child, Preschool; Delirium

2015